GaitQ
- Company typePrivate
- Founded2019
- HeadquartersOxford, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
GaitQ firmographics
Firmographics- Name
- GaitQ
- Legal name
- gaitQ Limited
- Website
- https://gaitq.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
GaitQ industry classification
Industry- Product category
- Wearable Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industry
- Mobility Aids (Wheelchairs, Scooters, Walkers, Canes) (HLAHAMAA)
Keywords
Where GaitQ is headquartered
LocationHeadquarters
- HQ city
- Oxford
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
GaitQ business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Wearable Medical Device Sales (gaitQ tempo): Sale of discreet wearable vibrational cueing system (gaitQ tempo) for people with Parkinson's. Device is a small, non-invasive system worn on both legs to help maintain fluid and stable gait.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | gaitQ tempo wearable device |
Go-to-market motion3 records
Distribution channels1 record
Marketing channels6 records
GaitQ product offering
Product offeringCore offering
GaitQ develops and sells gaitQ tempo™, a wearable vibrational cueing device for people with Parkinson's disease. The device delivers rhythmic vibrations as sensory cues to help reduce freezing of gait episodes and improve walking patterns, offering a drug-free, wearable solution for managing Parkinson's symptoms.
Product overview
GaitQ offers a single unified product: gaitQ tempo™, a wearable medical device designed for mobility enablement in Parkinson's disease. The device is a non-invasive vibrational cueing system worn on the lower legs that provides rhythmic sensory cues to bypass damaged neural pathways in the basal ganglia, helping users maintain fluid walking and reduce freezing of gait episodes. Powered by proprietary machine learning algorithms, the system delivers adaptive, personalized cueing based on real-time gait analysis.
Differentiator
Problem solved
Functional benefit
Brands
- gaitQ tempo: A small, non-invasive vibrational cueing system worn on both legs to help people with Parkinson's maintain a more fluid and stable gait. Clinically proven to help reduce freezing of gait (FoG) and lower the risk of falls.
Products and services
- gaitQ tempo™
Quantifiable outcome
- 55% reduction in gait freezing events and 73% reduction in freeze duration in clinical study
- +2 more outcomes
Companies that use GaitQ
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles1 record
GaitQ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
GaitQ partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- machineMDcoreJoint award of ~$1 million research grant from InnovateUK and Innosuisse for 18-month project collecting movement data from 100 UK and Swiss PwP. gaitQ and machineMD collaborating to record digital biomarkers including mobility and eye movement data to better predict Parkinson's Disease progression.
- University of Exetercore£1.4m collaboration with University of Exeter Medical School rehabilitation research team at NIHR Exeter Biomedical Research Centre. Project uses VSimulators facility combined with gaitQ tempo technology to restore independence in walking for individuals with Parkinson's and other gait-related challenges.
- University Hospital ZurichcoreResearch partner for 18-month joint project with machineMD. Data collected and analyzed at University Hospital Zurich (USZ) alongside University of Exeter to monitor Parkinson's development.
- Health Innovation Oxford & Thames ValleyminorCollaboration partner in £1.4m NIHR-funded project exploring gaitQ tempo impact on mobility including post-stroke recovery and hip/knee replacement aftermath.
- Parkinson's UKcoreEurope's largest charitable funder of Parkinson's research. Supports gaitQ development by facilitating patient and public involvement activities, building network, and advising on engagement with PwP, carers, clinicians. Confirmed continued support for development.
- Oxford Product DesignminorProduct design consultancy collaborated on gaitQ product design, recognized in MedTech Awards 2022 Design Award category finalist selection.
Scale indicators9 records
Recent moves5 records
Expansion highlights6 records
GaitQ competitors and assessment
Company assessmentDirect peers
- Global Kinetics: Australian company developing the Personal KinetiGraph (PKG) wrist-worn system for objective Parkinson's disease movement monitoring. Most direct competitor in Parkinson's-specific wearable technology for clinical and research use.
- Great Lakes NeuroTechnologies: US-based developer of Kinesia technology for Parkinson's movement assessment and biofeedback. Direct competitor in wearable neurological monitoring with similar clinical/research customer base.
- machineMD: Swiss neurodiagnostics company and gaitQ's joint research partner on the InnovateUK/Innosuisse project. Developing digital biomarker solutions for neurological diseases including Parkinson's - highly comparable in technology and target market.
- Functional Neuromodulation: Boston Scientific-backed developer of DBS therapies targeting gait and mobility in Parkinson's. Direct competitor addressing overlapping clinical indications with more invasive but established modality.
Broad incumbents
- Medtronic: Global medical device leader with Activa deep brain stimulation systems for Parkinson's disease. Competes indirectly by offering an established, reimbursed therapy for the same patient population.
- Abbott: Major neuromodulation player with Infinity DBS system approved for Parkinson's. Broad incumbent offering competing therapy options for advanced Parkinson's patients.
- CUE Health: Health monitoring company building connected diagnostic wearables. Comparable as a wearable health-tech business model, though focused on infectious disease diagnostics rather than neurological monitoring.
Emerging players
- Rune Labs: US-based precision neurology company using Apple Watch data (StrivePD app) for Parkinson's monitoring. Emerging competitor leveraging consumer hardware rather than dedicated devices.
- Hinge Health: Digital musculoskeletal care platform using sensors and wearables for MSK rehabilitation. Comparable in wearable-based physical therapy delivery, though targeting MSK rather than neurological conditions.
- Sword Health: Digital MSK and pelvic health therapy provider using wearable motion sensors and AI. Comparable in combining wearable hardware with digital therapy delivery for movement disorders.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
GaitQ social profiles
Digital presenceGaitQ financial estimates
Financial estimateRevenue estimate
Valuation estimate
GaitQ leadership team
Management profileNumber of profiles
Profiles6 records
GaitQ funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GaitQ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GaitQ
What does GaitQ do?
GaitQ develops and sells gaitQ tempo™, a wearable vibrational cueing device for people with Parkinson's disease. The device delivers rhythmic vibrations as sensory cues to help reduce freezing of gait episodes and improve walking patterns, offering a drug-free, wearable solution for managing Parkinson's symptoms.
Is GaitQ a public or private company?
GaitQ is a private company. It is classified as venture growth investor backed and is currently operating.
When was GaitQ founded?
GaitQ was founded in 2019. It employs 11 to 50 people.
Where is GaitQ based?
GaitQ is headquartered in Oxford, United Kingdom, in the Europe region.
How does GaitQ make money?
One revenue line is on record: wearable Medical Device Sales (gaitQ tempo).
Who are GaitQ's main competitors?
Direct peers on record are Global Kinetics, Great Lakes NeuroTechnologies, machineMD and Functional Neuromodulation. Broad incumbents are Medtronic, Abbott and CUE Health. Emerging players are Rune Labs, Hinge Health and Sword Health.
Does GaitQ have an API?
No public API is recorded for GaitQ.
What industry is GaitQ in?
GaitQ's product category is Wearable Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAHAMAA, Mobility Aids (Wheelchairs, Scooters, Walkers, Canes). Its NAICS code is 334510 and its SIC code is 3845.